Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.56B |
| Enterprise Value | 2.93B |
| P/E Ratio | 105 |
| PEG Ratio | 0.1 |
| Price/Sales Ratio | 3.38 |
| Price/Book Ratio | 2.68 |
| Enterprise/Revenue | 2.79 |
| Enterprise/EBITDA | 25.31 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.03 |
| Operating Margin | 0.07 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 1.45B |
| Revenue/Share | 3.11 |
| Gross Profit | 346.98M |
| EBITDA | 96.18M |
| Net Income | -30.75M |
| Diluted EPS | -0.08 |
Balance Sheet
| Total Cash | 816.28M |
| Total Cash/Share | 2.05 |
| Total Debt | 91.08M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 4.24 |
| Book Value Per Share | 4.08 |
Price History
| 52-Week Change | 2.94 |
| 52-Week High | 14.55 |
| 52-Week Low | 7.86 |
| Moving Average 50 Days | 10.87 |
| Moving Average 200 Days | 10.22 |
Statistics
| Average Volume | 23.01M |
| Shares Outstanding | 398.52M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.18 |
| Trailing Annual Dividend Yield | 1.71 |
| Payout Ratio | 0.14 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
